Uliano Guerrini Selected Research

2-(4-phenylphenoxy)-3-phenylpropanoic acid

3/2014

LT175 is a novel PPARα/γ ligand with potent insulin-sensitizing effects and reduced adipogenic properties.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Uliano Guerrini Research Topics

Disease

12	Stroke (Strokes) 01/2018 - 03/2002
10	Inflammation (Inflammations) 01/2021 - 03/2005
6	Proteinuria 01/2018 - 12/2004
4	Brain Ischemia (Cerebral Ischemia) 10/2008 - 02/2003
3	Ischemia 10/2006 - 02/2003
2	Neoplasms (Cancer) 10/2019 - 02/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 11/2013
2	Pathologic Processes 01/2018 - 11/2013
2	Myocardial Infarction 01/2015 - 01/2015
2	Body Weight (Weight, Body) 03/2014 - 03/2013
2	Type 2 Diabetes Mellitus (MODY) 03/2014 - 03/2013
2	Fibrosis (Cirrhosis) 12/2009 - 04/2007
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2006 - 03/2002
1	Cardiomegaly (Heart Hypertrophy) 01/2018
1	Cardiotoxicity 05/2014
1	Breast Neoplasms (Breast Cancer) 05/2014
1	Insulin Resistance 03/2014
1	Dyslipidemias (Dyslipidemia) 03/2014
1	Hemolysis 11/2013
1	Hypertensive Nephropathy 11/2013
1	Necrosis 01/2013
1	CADASIL 02/2012
1	Thrombosis (Thrombus) 07/2010
1	Hypertension (High Blood Pressure) 02/2009
1	Avitaminosis (Vitamin Deficiency) 08/2008
1	Seizures (Absence Seizure) 07/2008
1	Status Epilepticus (Complex Partial Status Epilepticus) 07/2008
1	Brain Injuries (Brain Injury) 01/2008
1	Renal Hypertension 02/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2007
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2005
1	Brain Infarction 02/2003

Drug/Important Bio-Agent (IBA)

5	SaltsIBA 01/2018 - 03/2002
4	Acute-Phase Proteins (Acute-Phase Protein)IBA 07/2010 - 10/2004
3	Rosuvastatin Calcium (Crestor)FDA Link 07/2010 - 03/2005
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2007 - 02/2003
3	Simvastatin (Zocor)FDA LinkGeneric 05/2006 - 02/2003
2	LipidsIBA 01/2018 - 03/2014
2	Valsartan (Vals)FDA Link 01/2015 - 12/2004
2	LigandsIBA 03/2014 - 10/2008
2	Insulin (Novolin)FDA Link 03/2014 - 03/2013
2	Glucose (Dextrose)FDA LinkGeneric 03/2014 - 03/2013
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 02/2012
2	NucleotidesIBA 01/2008 - 10/2006
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	Amino Acids FDA Link 10/2019
1	Fenofibrate (CiL)FDA LinkGeneric 01/2018
1	PPAR alphaIBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	Trastuzumab (Herceptin)FDA Link 05/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2014
1	ErbB Receptors (EGF Receptor)IBA 05/2014
1	2-(4-phenylphenoxy)-3-phenylpropanoic acidIBA 03/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2014
1	Deferoxamine (Desferal)FDA LinkGeneric 11/2013
1	HaptoglobinsIBA 11/2013
1	Hemoglobins (Hemoglobin)IBA 11/2013
1	IronIBA 11/2013
1	Chelating AgentsIBA 11/2013
1	Histone Deacetylase InhibitorsIBA 03/2013
1	dihydroethidiumIBA 01/2013
1	Acridine OrangeIBA 01/2013
1	2,5-dichloro-4-bromophenol (B 2)IBA 07/2010
1	prostaglandin endoperoxide receptorIBA 07/2010
1	terutrobanIBA 07/2010
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2010
1	ThromboxanesIBA 07/2010
1	Bovine Serum AlbuminIBA 02/2010
1	erucylphosphocholineIBA 02/2010
1	AldosteroneIBA 12/2009
1	SodiumIBA 02/2009
1	Peroxiredoxin IIIIBA 02/2009
1	Glycogen Synthase (Synthase I)IBA 02/2009
1	EnzymesIBA 02/2009
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 02/2009
1	S 35171IBA 02/2009
1	Urea (Carbamide)FDA LinkGeneric 02/2009
1	AntioxidantsIBA 02/2009
1	Contrast MediaIBA 08/2008
1	AlbuminsIBA 08/2008
1	Pilocarpine (Ocusert)FDA LinkGeneric 07/2008
1	Diazepam (Valium)FDA LinkGeneric 07/2008
1	LeukotrienesIBA 01/2008
1	Fibrinolysin FDA Link 04/2007
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2007
1	C-Reactive ProteinIBA 01/2007
1	U 0126 (UO 126)IBA 05/2006
1	NF-kappa B (NF-kB)IBA 05/2006
1	CytokinesIBA 05/2006
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 05/2006
1	Pentoxifylline (Trental)FDA LinkGeneric 09/2004
1	Peptide Hydrolases (Proteases)FDA Link 06/2003

Therapy/Procedure

4	Therapeutics 10/2019 - 02/2010
1	Vascular Access Devices (Arterial Line) 01/2015
1	Intraperitoneal Injections 05/2014
1	Adjuvant Chemotherapy 05/2014
1	Precision Medicine 02/2010